AIDS News and Research

RSS

New HIV/AIDS guide to help countries reach universal access

Today, at the XVII International AIDS Conference in Mexico City, the World Health Organization (WHO) launched a package of priority interventions designed to help low- and middle-income countries move towards universal access to HIV/AIDS prevention, treatment, care and support.

5 Aug 2008

Bionor Immuno trials new innovative therapeutic immunization designed to help existing HIV and AIDS patients

Bionor Immuno today announced that it has advanced its efforts to develop the first HIV therapeutic immunization with the dosing of patients in a global Phase 2b clinical trial of the company's lead candidate (Vacc-4x).

4 Aug 2008

Targeted action on HIV and tuberculosis needed to reach drug users

Health and criminal justice authorities need to provide targeted services to drug users, especially those who inject drugs, to prevent and treat tuberculosis (TB) and HIV. TB is a major cause of death for people living with HIV, but drug users who are HIV-positive face stigma, discrimination and barriers to accessing life-saving treatments.

4 Aug 2008

Mexico lifts regulation requiring AIDS drug companies to have manufacturing plants in Mexico in order to sell generics

On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.

4 Aug 2008

ShangRing - innovative circumcision device

With the recent endorsement by the World Health Organization (WHO) and scientists worldwide of adult male circumcision as an important strategy for HIV prevention, there is increased urgency to develop safe and cost-effective circumcision services. This is especially the case in Africa where HIV/AIDS continues to spread at an epidemic rate.

4 Aug 2008

Vietnam should prioritize HIV/AIDS prevention programs, Deputy Prime Minister says

Vietnamese local governments should prioritize HIV/AIDS prevention measures, particularly education and communication programs that target injection drug use among young people, Deputy Prime Minister Truong Vinh Trong said on Tuesday at a symposium on HIV prevention and drug detoxification in Hanoi, Vietnam, the Vietnam News Agency reports.

3 Aug 2008

NPR's 'Tell Me More' examines U.S. Hispanics, HIV/AIDS

NPR's "Tell Me More" on Monday featured a discussion about Hispanics and HIV/AIDS (Corley [1], "Tell Me More," NPR, 7/28). Hispanics account for about 14% of the U.S. population but represented 22% of new HIV/AIDS diagnoses in 2006, according to data reported last week by the Washington Post (Kaiser Daily HIV/AIDS Report, 7/23).

3 Aug 2008

New campaign aims to raise HIV awareness among migrant workers in China

Chinese groups and the International Labour Organization on Monday launched a three-year campaign that aims to increase HIV/AIDS awareness and prevention among the country's migrant worker population in the provinces of Anhui, Guangdong and Yunnan, as well as the Xinjiang Uygur autonomous region, China Daily reports (Guan, China Daily, 7/29).

3 Aug 2008

New HIV infections, deaths from AIDS-related causes down; epidemic not over

The number of deaths worldwide from AIDS-related causes decreased by 10% in 2007 to two million, compared with 2.2 million in 2006, according to UNAIDS' 2008 Report on the Global AIDS Epidemic, which was released Tuesday ahead of the XVII International AIDS Conference, the Los Angeles Times reports (Maugh, Los Angeles Times, 7/30).

3 Aug 2008

HIV in Kenya - 7.8% increase in 2007

HIV prevalence in Kenya increased to 7.8% in 2007, a slight increase from the 6.7% prevalence recorded in 2003, according to a survey released by the government on Tuesday, the Associated Press reports. According to the Associated Press, the increase in the percentage of the population living with HIV likely is because of wider access to antiretroviral drugs.

3 Aug 2008

HIV/AIDS advocates protest stigma, discrimination ahead of AIDS conference

HIV/AIDS advocates in Mexico City have begun protesting the problems of stigma, discrimination and a lack of access to antiretroviral drugs in Latin America ahead of next week's XVII International AIDS Conference in Mexico City, Agence France-Presse reports (Rosenthal, Agence France-Presse, 7/29).

3 Aug 2008

Eliminating funds for HIV/AIDS vaccine research, shifting funds to treatment 'dangerous sentiment,' opinion piece says

The call to eliminate all funding for HIV/AIDS vaccine research and prevention programs and "shifting" those funds to the expansion of HIV/AIDS treatment is a "dangerous sentiment" that is "sweeping over the AIDS establishment," Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, writes in an International Herald Tribune opinion piece.

3 Aug 2008

Reuters examines how laws, conservative attitudes are hampering efforts to fight HIV/AIDS in Malaysia

Reuters on Thursday examined how some laws and widespread conservative attitudes are hindering efforts to fight the spread of HIV/AIDS in Malaysia, a predominantly Muslim country where high-risk groups are driven "deeper underground" because of the situation.

3 Aug 2008

Editorials respond to PEPFAR reauthorization

President Bush on Wednesday signed into law legislation (HR 5501) that reauthorizes the President's Emergency Plan for AIDS Relief at $48 billion through 2013. Two newspapers have published editorials in response to the bill.

3 Aug 2008

Abbott Labs agrees to settle lawsuit over antiretroviral Norvir pricing

Abbott Laboratories on Wednesday agreed to pay between $10 million and $27.5 million to settle an antitrust lawsuit filed by HIV/AIDS advocates and other drug companies over an increase in the price of the company's antiretroviral drug Norvir, the AP/International Herald Tribune reports (AP/International Herald Tribune, 7/31).

3 Aug 2008

Certain HIV treatment less effective when used with rifampicin-based anti-tuberculosis therapy

Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy, according to a study in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

3 Aug 2008

Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapy

Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.

3 Aug 2008

New figures show need for national HIV/AIDS srategy

The federal Centers for Disease Control and Prevention's (CDC) long anticipated revised estimate of annual new cases of HIV infections was revealed in a paper published in the Aug. 6, 2008 issue of the Journal of the American Medical Association (JAMA). The revised estimated number of new infections suggests that the HIV epidemic here in the United States is more severe than current statistics portray.

3 Aug 2008

Update of treatment guidelines for HIV infection recommended by experts

An evaluation of the latest information on the treatment of the adult human immunodeficiency virus (HIV) has led an international panel of experts to update the guidelines and recommendations for antiretroviral treatment of HIV.

3 Aug 2008

Merck announces significant price cuts on two of its AIDS drugs, Stocrin and Isentress

As more than 20,000 people from around the world gather this weekend for the start of the XVII International AIDS Conference in Mexico City, AIDS Healthcare Foundation (AHF) the US-based NGO which provides HIV/AIDS medical care and/or services to more than 79,000 individuals in 20 countries worldwide-including at four free treatment clinics in Mexico-commended Merck & Company (known as Merck, Sharp & Dohme in Mexico) over price cuts on two of its key AIDS drugs in Mexico which were announced yesterday before Sunday's opening of the AIDS conference.

3 Aug 2008

AIDS News and Research

New HIV/AIDS guide to help countries reach universal access

Bionor Immuno trials new innovative therapeutic immunization designed to help existing HIV and AIDS patients

Targeted action on HIV and tuberculosis needed to reach drug users

Mexico lifts regulation requiring AIDS drug companies to have manufacturing plants in Mexico in order to sell generics

ShangRing - innovative circumcision device

Vietnam should prioritize HIV/AIDS prevention programs, Deputy Prime Minister says

NPR's 'Tell Me More' examines U.S. Hispanics, HIV/AIDS

New campaign aims to raise HIV awareness among migrant workers in China

New HIV infections, deaths from AIDS-related causes down; epidemic not over

HIV in Kenya - 7.8% increase in 2007

HIV/AIDS advocates protest stigma, discrimination ahead of AIDS conference

Eliminating funds for HIV/AIDS vaccine research, shifting funds to treatment 'dangerous sentiment,' opinion piece says

Reuters examines how laws, conservative attitudes are hampering efforts to fight HIV/AIDS in Malaysia

Editorials respond to PEPFAR reauthorization

Abbott Labs agrees to settle lawsuit over antiretroviral Norvir pricing

Certain HIV treatment less effective when used with rifampicin-based anti-tuberculosis therapy

Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapy

New figures show need for national HIV/AIDS srategy

Update of treatment guidelines for HIV infection recommended by experts

Merck announces significant price cuts on two of its AIDS drugs, Stocrin and Isentress

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News